Kenneth Mills

(Mr. Kenneth Mills)

Currently holds a position at Regenxbio Inc

Positions
Position Company Period
President, Chief Executive Officer, Executive Director Regenxbio Inc March 1, 2009 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-04-17 2024-04-15
US Regenxbio Inc (RGNX)
PS Planned sale
15,000 -3.5%
18.19
272,871 USD
15,000 -3.5% 18.19 272,871 USD
2024-03-18 2024-03-14
US Regenxbio Inc (RGNX)
PS Planned sale
15,000 -3.5%
21.86
327,942 USD
15,000 -3.5% 21.86 327,942 USD
2024-02-16 2024-02-14
US Regenxbio Inc (RGNX)
PS Planned sale
10,348 -2.5%
16.88
174,723 USD
10,348 -2.5% 16.88 174,723 USD
2024-02-16 2024-02-14
US Regenxbio Inc (RGNX)
PS Planned sale
4,652 -1.1%
16.47
76,626 USD
4,652 -1.1% 16.47 76,626 USD
2024-01-18 2024-01-16
US Regenxbio Inc (RGNX)
PS Planned sale
45,000 -9.9%
15.18
682,992 USD
45,000 -9.9% 15.18 682,992 USD
2023-12-21 2023-12-19
US Regenxbio Inc (RGNX)
PS Planned sale
45,000 -11.2%
19.69
885,825 USD
45,000 -11.2% 19.69 885,825 USD
2021-11-10 2021-11-08
US Regenxbio Inc (RGNX)
PS Planned sale
1,500 -0.5%
40.00
60,000 USD
1,500 -0.5% 40.00 60,000 USD
2021-09-29 2021-09-27
US Regenxbio Inc (RGNX)
PS Planned sale
1,500 -0.5%
42.19
63,285 USD
1,500 -0.5% 42.19 63,285 USD
2021-06-28 2021-06-25
US Regenxbio Inc (RGNX)
PS Planned sale
1,500 -0.5%
40.25
60,375 USD
1,500 -0.5% 40.25 60,375 USD
2021-06-28 2021-06-24
US Regenxbio Inc (RGNX)
PS Planned sale
4,500 -1.6%
40.02
180,090 USD
4,500 -1.6% 40.02 180,090 USD
2021-03-01 2021-02-25
US Regenxbio Inc (RGNX)
PS Planned sale
1,500 -0.5%
40.77
61,155 USD
1,500 -0.5% 40.77 61,155 USD
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PS Planned sale
5,211 -1.8%
44.99
234,443 USD
5,211 -1.8% 44.99 234,443 USD
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PS Planned sale
974 -0.3%
44.05
42,905 USD
974 -0.3% 44.05 42,905 USD
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PS Planned sale
315 -0.1%
42.64
13,432 USD
315 -0.1% 42.64 13,432 USD
2021-01-11 2021-01-07
US Regenxbio Inc (RGNX)
PS Planned sale
1,500 -0.5%
50.01
75,015 USD
1,500 -0.5% 50.01 75,015 USD
2020-12-30 2020-12-28
US Regenxbio Inc (RGNX)
PS Planned sale
1,853 -0.8%
49.16
91,093 USD
1,853 -0.8% 49.16 91,093 USD
2020-12-30 2020-12-28
US Regenxbio Inc (RGNX)
PS Planned sale
4,647 -1.9%
48.47
225,240 USD
4,647 -1.9% 48.47 225,240 USD
2020-12-28 2020-12-23
US Regenxbio Inc (RGNX)
PS Planned sale
4,500 -1.8%
50.00
225,000 USD
4,500 -1.8% 50.00 225,000 USD
2020-12-18 2020-12-16
US Regenxbio Inc (RGNX)
PS Planned sale
15,000 -5.9%
45.00
675,000 USD
15,000 -5.9% 45.00 675,000 USD
2020-12-14 2020-12-10
US Regenxbio Inc (RGNX)
PS Planned sale
4,500 -1.8%
40.00
180,000 USD
4,500 -1.8% 40.00 180,000 USD
2019-09-23 2019-09-19
US Regenxbio Inc (RGNX)
PS Planned sale
7,773 -3.1%
39.91
310,220 USD
7,773 -3.1% 39.91 310,220 USD
2019-09-23 2019-09-19
US Regenxbio Inc (RGNX)
PS Planned sale
2,227 -0.9%
39.19
87,276 USD
2,227 -0.9% 39.19 87,276 USD
2019-07-23 2019-07-19
US Regenxbio Inc (RGNX)
PS Planned sale
2,300 -0.9%
49.97
114,931 USD
2,300 -0.9% 49.97 114,931 USD
2019-07-23 2019-07-19
US Regenxbio Inc (RGNX)
PS Planned sale
12,700 -4.9%
49.40
627,380 USD
12,700 -4.9% 49.40 627,380 USD
2019-06-21 2019-06-19
US Regenxbio Inc (RGNX)
PS Planned sale
4,120 -1.6%
53.25
219,390 USD
4,120 -1.6% 53.25 219,390 USD
2019-06-21 2019-06-19
US Regenxbio Inc (RGNX)
PS Planned sale
10,880 -4.2%
52.27
568,698 USD
10,880 -4.2% 52.27 568,698 USD
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PS Planned sale
300 -0.1%
43.99
13,197 USD
300 -0.1% 43.99 13,197 USD
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PS Planned sale
10,559 -4.1%
43.32
457,416 USD
10,559 -4.1% 43.32 457,416 USD
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PS Planned sale
4,141 -1.6%
42.08
174,253 USD
4,141 -1.6% 42.08 174,253 USD
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PS Planned sale
100 -0.0%
53.05
5,305 USD
100 -0.0% 53.05 5,305 USD
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PS Planned sale
1,300 -0.5%
52.33
68,029 USD
1,300 -0.5% 52.33 68,029 USD
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PS Planned sale
3,270 -1.3%
51.07
166,999 USD
3,270 -1.3% 51.07 166,999 USD
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PS Planned sale
6,929 -2.7%
50.31
348,598 USD
6,929 -2.7% 50.31 348,598 USD
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PS Planned sale
3,401 -1.3%
49.29
167,635 USD
3,401 -1.3% 49.29 167,635 USD
2019-03-21 2019-03-19
US Regenxbio Inc (RGNX)
PS Planned sale
9,130 -3.6%
58.74
536,296 USD
9,130 -3.6% 58.74 536,296 USD
2019-03-21 2019-03-19
US Regenxbio Inc (RGNX)
PS Planned sale
5,870 -2.2%
58.21
341,693 USD
5,870 -2.2% 58.21 341,693 USD
2019-02-19 2019-02-15
US Regenxbio Inc (RGNX)
PS Planned sale
8,066 -3.2%
47.84
385,877 USD
8,066 -3.2% 47.84 385,877 USD
2019-02-19 2019-02-15
US Regenxbio Inc (RGNX)
PS Planned sale
3,522 -1.4%
47.30
166,591 USD
3,522 -1.4% 47.30 166,591 USD
2019-02-19 2019-02-15
US Regenxbio Inc (RGNX)
PS Planned sale
3,412 -1.3%
45.96
156,816 USD
3,412 -1.3% 45.96 156,816 USD
2019-01-17 2019-01-15
US Regenxbio Inc (RGNX)
PS Planned sale
3,140 -1.5%
44.40
139,416 USD
3,140 -1.5% 44.40 139,416 USD
2019-01-17 2019-01-15
US Regenxbio Inc (RGNX)
PS Planned sale
11,860 -5.5%
43.70
518,282 USD
11,860 -5.5% 43.70 518,282 USD